By Lawrie Holmes2022-08-23T15:29:00
Life Science REIT has drawn down £37.2m from its £150m debt facility with HSBC to fund the development of sites in Cambridge and London.
You must be logged in to continue
Register for free to finish this article.
Sign up now for the following benefits:
To access this article REGISTER NOW
Would you like print copies, app and digital replica access too? SUBSCRIBE for as little as £6 per week.
Registered users and subscribers SIGN IN here to continue